Enovis (ENOV) Other Non-Current Liabilities (2010 - 2026)
Enovis (ENOV) posted quarterly Other Non-Current Liabilities of $393.8 million for Q2 2026, up 9.18% year-over-year from $360.7 million in Q2 2025, and down 7.25% quarter-over-quarter from $424.6 million in Q4 2025.
Enovis (ENOV) Other Non-Current Liabilities (2010 - 2026) Analysis & Trends
Enovis (ENOV) has reported Other Non-Current Liabilities for 17 consecutive years, with $393.8 million the latest figure, recorded in Q2 2026.
- In Q2 2026, Other Non-Current Liabilities rose 9.18% year-over-year to $393.8 million; the TTM figure through Apr 2026 stood at $393.8 million (up 9.18% YoY), while the FY2025 annual figure was $424.6 million, up 61.12% from the prior year.
- Other Non-Current Liabilities slipped to $393.8 million in Q2 2026 per ENOV's latest filing, from $424.6 million in the prior quarter.
- Across five years, Other Non-Current Liabilities topped out at $601.0 million in Q2 2022 and bottomed at $130.7 million in Q3 2022.
- Historically, Other Non-Current Liabilities has averaged $289.2 million across 5 years, with a median of $255.2 million in 2024.
- Annual changes were most pronounced in 2022 — Other Non-Current Liabilities plunged 79.17% — and 2024, when it surged 96.44%.
- Enovis' Other Non-Current Liabilities stood at $167.0 million in 2022, then grew by 22.27% to $204.2 million in 2023, then climbed by 29.06% to $263.5 million in 2024, then surged by 61.12% to $424.6 million in 2025, then decreased by 7.25% to $393.8 million in 2026.
- Business Quant data shows ENOV's Other Non-Current Liabilities at $393.8 million in Q2 2026, $424.6 million in Q4 2025, and $437.0 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn |
| 10 | Enovis | 1.50 Bn | 1.48 Bn | 359.25 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jul 3, 2026 | 368.63 Mn |
| Apr 3, 2026 | 393.81 Mn |
| Dec 31, 2025 | 424.57 Mn |
| Oct 3, 2025 | 437.01 Mn |
| Jul 4, 2025 | 450.56 Mn |
| Apr 4, 2025 | 360.70 Mn |
| Dec 31, 2024 | 263.52 Mn |
| Sep 27, 2024 | 313.76 Mn |
| Jun 28, 2024 | 255.20 Mn |
| Mar 29, 2024 | 249.05 Mn |
| Dec 31, 2023 | 204.18 Mn |
| Sep 29, 2023 | 159.73 Mn |
| Jun 30, 2023 | 191.55 Mn |
| Mar 31, 2023 | 170.53 Mn |
| Dec 31, 2022 | 166.99 Mn |
| Sep 30, 2022 | 130.67 Mn |
| Jul 1, 2022 | 144.24 Mn |
| Apr 1, 2022 | 601.02 Mn |
| Dec 31, 2021 | 122.16 Mn |
| Oct 1, 2021 | 627.37 Mn |